000 01637 a2200445 4500
005 20250517184444.0
264 0 _c20180813
008 201808s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2017.10.137
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRabadiya, Samir
245 0 0 _aMagnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cJan 2018
300 _a919-927 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCardiomegaly
_xetiology
650 0 4 _aDiabetes Mellitus, Experimental
_xdrug therapy
650 0 4 _aDiabetes Mellitus, Type 1
_xcomplications
650 0 4 _aDiabetic Cardiomyopathies
_xprevention & control
650 0 4 _aDisease Progression
650 0 4 _aDyslipidemias
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHyperglycemia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Estrogen
_xdrug effects
650 0 4 _aStreptozocin
650 0 4 _aUp-Regulation
650 0 4 _aValproic Acid
_xpharmacology
700 1 _aBhadada, Shradhha
700 1 _aDudhrejiya, Ashvin
700 1 _aVaishnav, Devendra
700 1 _aPatel, Bhoomika
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 97
_gp. 919-927
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2017.10.137
_zAvailable from publisher's website
999 _c27787188
_d27787188